tm
Seeing Is Believing
tm
Seeing Is Believing
RSLS is currently covered by 2 analysts with an average price target of $6643.67. This is a potential upside of $6643.5 (3907941.18%) from yesterday's end of day stock price of $0.17.
ReShape Lifesciences's activity chart (see below) currently has 3 price targets and 8 ratings on display. The stock rating distribution of RSLS is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 20.83% with an average time for these price targets to be met of 62.75 days.
Highest price target for RSLS is $69, Lowest price target is $22, average price target is $6643.67.
Most recent stock forecast was given by BEN HAYNOR from ALLIANCE GLOBAL PARTNERS on 26-May-2022. First documented stock forecast 18-Feb-2021.
Currently out of the existing stock ratings of RSLS, 3 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
1 years 11 months 11 days ago
1/2 (50%)
$305.5 (103.74%)
5
Buy
400
2 years 1 months 8 days ago
0/1 (0%)
$243.5 (155.59%)
Hold
4 years 11 months 15 days ago
1/3 (33.33%)
$11700 (50.61%)
246
Buy
5 years 2 months 12 days ago
0/3 (0%)
$14325 (96.69%)
What is RSLS (ReShape Lifesciences) average time for price targets to be met?
Which analyst has the current highest performing score on RSLS (ReShape Lifesciences) with a proven track record?
Which analyst has the current lower performing score on RSLS (ReShape Lifesciences) with a proven track record?
Which analyst has the most public recommendations on RSLS (ReShape Lifesciences)?
Which analyst is the currently most bullish on RSLS (ReShape Lifesciences)?
Which analyst is the currently most reserved on RSLS (ReShape Lifesciences)?
